Gaziano, J., Brotons, C., Coppolecchia, R., Cricelli, C., Darius, H., Gorelick, P., . . . Committee, A. (2018). Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial. Elsevier.
Style de citation Chicago (17e éd.)Gaziano, J., et al. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-blind, Placebo-controlled Trial. Elsevier, 2018.
Style de citation MLA (9e éd.)Gaziano, J., et al. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-blind, Placebo-controlled Trial. Elsevier, 2018.